\-\ Texto\\:\\ \ \(0\)\
\-\ \\â\\€\\¢\\ no\\ current\\ physical\\ exam\\ findings\ \(0\)\
\-\ \\â\\€\\¢\\ lp\\:\\ 5\\ oligoclonal\\ bands\\ on\\ csf\\,\\ lumbar\\ puncture\\ sampling\ \(0\)\
\-\ \\â\\€\\¢\\ patient\\ will\\ continue\\ to\\ follow\\-up\\ with\\ neurology\ \(0\)\
\-\ \\â\\€\\¢\\ repeat\\ scans\\ will\\ be\\ performed\\ when\\ clinically\\ indicated\ \(0\)\
\-\ within\\ the\\ right\\ corona\\ radiata\\,\\ there\\ is\\ continued\\ presence\\ of\\ a\\ t2\\ and\\ flair\\ hyperintense\\ lesion\\,\\ which\\ displays\\ interval\\ slight\\ decrease\\ in\\ size\\ and\\ clarity\\ of\\ margins\\.\\ \\ additionally\\,\\ there\\ is\\ no\\ longer\\ post\\-contrast\\ enhancement\\ of\\ the\\ lesion\\.\\ \\ gray\\ matter\\/white\\ matter\\ differentiation\\ is\\,\\ otherwise\\,\\ preserved\\ throughout\\.\ \(0\)\
\-\ prior\\ study\\ dated\\ 1\\ week\\ earlier\\ shows\\ t2\\ high\\ signal\\ within\\ the\\ corona\\ radiata\\ and\\ a\\ smoothly\\ uniform\\ enhancement\\ pattern\\ likely\\ represent\\ a\\ demyelinating\\ plaque\\ \\(tumefactive\\ multiple\\ sclerosis\\)\\.\ \(0\)\
\-\ tumefactive\\ multiple\\ sclerosis\ \(2\)\
\-\ \\â\\€\\¢\\ tumefactive\\ ms\ \(0\)\
\-\ \\â\\€\\¢\\ gbm\ \(0\)\
\-\ \\â\\€\\¢\\ primary\\ cns\\ lymphoma\ \(0\)\
\-\ 20\\ year\\-old\\ woman\\ with\\ left\\ side\\ upper\\ and\\ lower\\ weakness\\ 3\\ weeks\\ ago\\.\\ now\\ asymptomatic\\.\\ seen\\ by\\ hometown\\ er\\,\\ ct\\ scan\\ negative\\.\\ evaluated\\ by\\ mri\\ 1\\ week\\ ago\\ which\\ demonstrated\\ an\\ enhancing\\ brain\\ lesion\\.\\ \\ please\\ reevaluate\\.\ \(0\)\
\-\ this\\ case\\ is\\ interesting\\ because\\ the\\ follow\\-up\\ study\\ was\\ performed\\ a\\ week\\ after\\ the\\ initial\\ study\\,\\ which\\ was\\ 5\\ weeks\\ earlier\\ than\\ originally\\ planned\\.\\ \\ the\\ patient\\ was\\ able\\ to\\ schedule\\ the\\ repeat\\ exam\\ due\\ to\\ an\\ opening\\ in\\ the\\ schedule\\ and\\ did\\ so\\ shortly\\ after\\ the\\ order\\ was\\ submitted\\.\\ \\ the\\ dramatic\\ lesion\\ enhancement\\ on\\ the\\ original\\ study\\ has\\ resolved\\ which\\ appears\\ to\\ signal\\ radiographic\\ correlation\\ with\\ resolution\\ of\\ clinical\\ signs\\ and\\ symptoms\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ tumefactive\\:\\ 0\\.06650218744532735\ \(0\)\
\-\ radiata\\:\\ 0\\.056415734576212385\ \(0\)\
\-\ schedule\\:\\ 0\\.056415734576212385\ \(0\)\
\-\ corona\\:\\ 0\\.055177576505310716\ \(0\)\
\-\ study\\:\\ 0\\.04516676878489894\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.0440526122938603\ \(0\)\
\-\ hometown\\:\\ 0\\.03540368844966465\ \(0\)\
\-\ week\\:\\ 0\\.03496404118467745\ \(0\)\
\-\ earlier\\:\\ 0\\.0338987837255575\ \(0\)\
\-\ clarity\\:\\ 0\\.032619964832958044\ \(0\)\
\-\ matter\\/white\\:\\ 0\\.032619964832958044\ \(0\)\
\-\ reevaluate\\:\\ 0\\.032619964832958044\ \(0\)\
\-\ repeat\\:\\ 0\\.032286970910600454\ \(0\)\
\-\ dated\\:\\ 0\\.029836241216251433\ \(0\)\
\-\ lesion\\:\\ 0\\.027960726522095653\ \(0\)\
\-\ enhancement\\:\\ 0\\.027596250194253446\ \(0\)\
\-\ oligoclonal\\:\\ 0\\.02615635875892551\ \(0\)\
\-\ which\\:\\ 0\\.025624812646466644\ \(0\)\
\-\ ago\\:\\ 0\\.025548022657006012\ \(0\)\
\-\ sampling\\:\\ 0\\.025424143671399585\ \(0\)\
\-\ sclerosis\\:\\ 0\\.02465313440503088\ \(0\)\
\-\ lp\\:\\ 0\\.024025321606065388\ \(0\)\
\-\ displays\\:\\ 0\\.023372635142218903\ \(0\)\
\-\ smoothly\\:\\ 0\\.02298986333577583\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.022329614389090296\ \(0\)\
\-\ dramatic\\:\\ 0\\.02216739581510911\ \(0\)\
\-\ post\\-contrast\\:\\ 0\\.021612575178639966\ \(0\)\
\-\ will\\:\\ 0\\.02147374311951118\ \(0\)\
\-\ demyelinating\\:\\ 0\\.02124159798935878\ \(0\)\
\-\ opening\\:\\ 0\\.02124159798935878\ \(0\)\
\-\ puncture\\:\\ 0\\.021125182178622828\ \(0\)\
\-\ neurology\\:\\ 0\\.02090201008563162\ \(0\)\
\-\ plaque\\:\\ 0\\.020690589469224304\ \(0\)\
\-\ bands\\:\\ 0\\.02048974440667546\ \(0\)\
\-\ original\\:\\ 0\\.02048974440667546\ \(0\)\
\-\ preserved\\:\\ 0\\.02029846710149773\ \(0\)\
\-\ gbm\\:\\ 0\\.02029846710149773\ \(0\)\
\-\ interesting\\:\\ 0\\.02029846710149773\ \(0\)\
\-\ submitted\\:\\ 0\\.02029846710149773\ \(0\)\
\-\ uniform\\:\\ 0\\.020115887285928426\ \(0\)\
\-\ 5\\:\\ 0\\.02008160981882862\ \(0\)\
\-\ planned\\:\\ 0\\.019535239780662933\ \(0\)\
\-\ shortly\\:\\ 0\\.019535239780662933\ \(0\)\
\-\ weeks\\:\\ 0\\.019480142625712033\ \(0\)\
\-\ t2\\:\\ 0\\.019426415813255837\ \(0\)\
\-\ longer\\:\\ 0\\.019383672198402504\ \(0\)\
\-\ originally\\:\\ 0\\.019383672198402504\ \(0\)\
\-\ performed\\:\\ 0\\.019137175351223445\ \(0\)\
\-\ correlation\\:\\ 0\\.018894154858607175\ \(0\)\
\-\ continue\\:\\ 0\\.018517372709138682\ \(0\)\
\-\ ms\\:\\ 0\\.01834145856191622\ \(0\)\
\-\ differentiation\\:\\ 0\\.018284492156326035\ \(0\)\
\-\ signal\\:\\ 0\\.018096982572472116\ \(0\)\
\-\ cns\\:\\ 0\\.017561715532032857\ \(0\)\
\-\ order\\:\\ 0\\.017200477633788118\ \(0\)\
\-\ interval\\:\\ 0\\.016829500444506932\ \(0\)\
\-\ gray\\:\\ 0\\.01679031901902354\ \(0\)\
\-\ resolved\\:\\ 0\\.01663730758837185\ \(0\)\
\-\ 1\\:\\ 0\\.016331938698471538\ \(0\)\
\-\ able\\:\\ 0\\.01617681398066045\ \(0\)\
\-\ slight\\:\\ 0\\.016143485455300227\ \(0\)\
\-\ current\\:\\ 0\\.016077646861823613\ \(0\)\
\-\ scans\\:\\ 0\\.01598086954624506\ \(0\)\
\-\ was\\:\\ 0\\.015875944131946776\ \(0\)\
\-\ flair\\:\\ 0\\.015733649092432075\ \(0\)\
\-\ evaluated\\:\\ 0\\.015733649092432075\ \(0\)\
\-\ decrease\\:\\ 0\\.01570378974107658\ \(0\)\
\-\ so\\:\\ 0\\.015615521039394752\ \(0\)\
\-\ margins\\:\\ 0\\.01558652405958155\ \(0\)\
\-\ please\\:\\ 0\\.015227461458314143\ \(0\)\
\-\ exam\\:\\ 0\\.015078184256622796\ \(0\)\
\-\ represent\\:\\ 0\\.015071981489716993\ \(0\)\
\-\ clinically\\:\\ 0\\.015046643460828379\ \(0\)\
\-\ additionally\\:\\ 0\\.014873617010481746\ \(0\)\
\-\ indicated\\:\\ 0\\.014849496431926679\ \(0\)\
\-\ resolution\\:\\ 0\\.014801685578487649\ \(0\)\
\-\ continued\\:\\ 0\\.014777991915326248\ \(0\)\
\-\ lumbar\\:\\ 0\\.014593312745680374\ \(0\)\
\-\ multiple\\:\\ 0\\.01445627312031541\ \(0\)\
\-\ csf\\:\\ 0\\.014331302617694826\ \(0\)\
\-\ hyperintense\\:\\ 0\\.014247631585956506\ \(0\)\
\-\ after\\:\\ 0\\.01420081287236307\ \(0\)\
\-\ matter\\:\\ 0\\.013511967752613645\ \(0\)\
\-\ er\\:\\ 0\\.013165398220674545\ \(0\)\
\-\ pattern\\:\\ 0\\.013118242325587462\ \(0\)\
\-\ within\\:\\ 0\\.013093424966956478\ \(0\)\
\-\ radiographic\\:\\ 0\\.013025559806380455\ \(0\)\
\-\ throughout\\:\\ 0\\.012846374804417375\ \(0\)\
\-\ appears\\:\\ 0\\.012774011328503006\ \(0\)\
\-\ weakness\\:\\ 0\\.01274542712059592\ \(0\)\
\-\ year\\-old\\:\\ 0\\.01260548040842657\ \(0\)\
\-\ presence\\:\\ 0\\.012456970355249513\ \(0\)\
\-\ did\\:\\ 0\\.012391239522059934\ \(0\)\
\-\ 20\\:\\ 0\\.01233941861910448\ \(0\)\
\-\ otherwise\\:\\ 0\\.01232656720251544\ \(0\)\
\-\ signs\\:\\ 0\\.012077814995927928\ \(0\)\
\-\ because\\:\\ 0\\.01200609765697208\ \(0\)\
\-\ side\\:\\ 0\\.011889343380578597\ \(0\)\
\-\ now\\:\\ 0\\.011731387910448383\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.01160077268271521\ \(0\)\
\-\ size\\:\\ 0\\.011505525587866551\ \(0\)\
\-\ by\\:\\ 0\\.011428681953774094\ \(0\)\
\-\ initial\\:\\ 0\\.011371815836463083\ \(0\)\
\-\ enhancing\\:\\ 0\\.010762865593914695\ \(0\)\
\-\ clinical\\:\\ 0\\.010559477108698812\ \(0\)\
\-\ brain\\:\\ 0\\.01032671294499101\ \(0\)\
\-\ negative\\:\\ 0\\.01024947855973845\ \(0\)\
\-\ there\\:\\ 0\\.010214582782851313\ \(0\)\
\-\ primary\\:\\ 0\\.010166201859018861\ \(0\)\
\-\ demonstrated\\:\\ 0\\.010069959768903482\ \(0\)\
\-\ when\\:\\ 0\\.009828639508498015\ \(0\)\
\-\ lymphoma\\:\\ 0\\.00980802664413448\ \(0\)\
\-\ likely\\:\\ 0\\.009679879381267695\ \(0\)\
\-\ scan\\:\\ 0\\.009607515905353326\ \(0\)\
\-\ an\\:\\ 0\\.009491284050479757\ \(0\)\
\-\ shows\\:\\ 0\\.009435235741883046\ \(0\)\
\-\ high\\:\\ 0\\.00939175124930448\ \(0\)\
\-\ due\\:\\ 0\\.009157739570091725\ \(0\)\
\-\ is\\:\\ 0\\.009032783588509648\ \(0\)\
\-\ than\\:\\ 0\\.008992164075977003\ \(0\)\
\-\ prior\\:\\ 0\\.008811697880330776\ \(0\)\
\-\ \\,\\:\\ 0\\.00869751214513373\ \(0\)\
\-\ symptoms\\:\\ 0\\.00855284127268329\ \(0\)\
\-\ physical\\:\\ 0\\.008419699877836298\ \(0\)\
\-\ upper\\:\\ 0\\.008281447812725776\ \(0\)\
\-\ 3\\:\\ 0\\.008036046291994135\ \(0\)\
\-\ woman\\:\\ 0\\.007927321074252635\ \(0\)\
\-\ mri\\:\\ 0\\.007884641987608914\ \(0\)\
\-\ lower\\:\\ 0\\.007718321563710291\ \(0\)\
\-\ case\\:\\ 0\\.007508049931193857\ \(0\)\
\-\ findings\\:\\ 0\\.007304566007188592\ \(0\)\
\-\ no\\:\\ 0\\.006911197997620899\ \(0\)\
\-\ patient\\:\\ 0\\.0068802564732239994\ \(0\)\
\-\ to\\:\\ 0\\.006860531862537931\ \(0\)\
\-\ seen\\:\\ 0\\.0067816370083039765\ \(0\)\
\-\ has\\:\\ 0\\.006444578194756136\ \(0\)\
\-\ a\\:\\ 0\\.00637108115371247\ \(0\)\
\-\ the\\:\\ 0\\.006107398119437285\ \(0\)\
\-\ on\\:\\ 0\\.005814385641489382\ \(0\)\
\-\ be\\:\\ 0\\.005292195676080036\ \(0\)\
\-\ ct\\:\\ 0\\.004800416278682903\ \(0\)\
\-\ \\:\\:\\ 0\\.004539256289119136\ \(0\)\
\-\ and\\:\\ 0\\.004337566403185987\ \(0\)\
\-\ this\\:\\ 0\\.0038599888084904937\ \(0\)\
\-\ left\\:\\ 0\\.0038397801978831913\ \(0\)\
\-\ right\\:\\ 0\\.0036210108799615125\ \(0\)\
\-\ in\\:\\ 0\\.0033847167079538547\ \(0\)\
\-\ \\(\\:\\ 0\\.002901051109413094\ \(0\)\
\-\ \\)\\:\\ 0\\.0028656132213385746\ \(0\)\
\-\ of\\:\\ 0\\.0018715470007708982\ \(0\)\
\-\ \\.\\:\\ 0\\.0017108210167395795\ \(0\)\
\-\ with\\:\\ 0\\.0014096888685528886\ \(0\)\
